Log In
BCIQ
Print this Print this
 

GeneSight MTHFR

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionGenetic test that detects mutations in the methylenetetrahydrofolate reductase (MTHFR) gene
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationPersonal genomics testing
Indication DetailsDetermine if folic acid supplementation is necessary
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$410.0M

$225.0M

$185.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/01/2016

$410.0M

$225.0M

$185.0M

Get a free BioCentury trial today